Ofatumumab 20mg/0.4ml solution for injection pre-filled disposable devices
NHS hospitals in England used £202,371,060 of indicative cost of Ofatumumab 20mg/0.4ml solution for injection pre-filled disposable devices in the 12 months to July 2026, about 0.8% of all hospital medicines spend. That is up 30.3% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Ofatumumab 20mg/0.4ml solution for injection pre-filled disposable devices: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Ofatumumab 20mg/0.4ml solution for injection pre-filled disposable devices most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Salford Royal Nhs Foundation Trust | £20,315,910 |
| University College London Foundation Tr | £19,089,075 |
| The Walton Centre Nhs Foundation Trust | £9,446,033 |
| Sheffield Teaching Hospitals Nhs Trust | £8,778,885 |
| St George's Univ Hosps Foundation Nhst | £7,813,238 |
| Western Sussex Hospitals Nhs Found Trust | £7,093,853 |
| University Hospital Southampton Nhs Ft | £7,017,735 |
| North Bristol Nhs Trust | £6,183,428 |
| Cambridge Univ Hosp Nhs Foundation Trust | £6,165,518 |
| King's College Hpl Nhs Foundation Trust | £5,699,858 |
The primary-care picture
Ofatumumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Ofatumumab medicine page.